These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8591734)

  • 21. Preclinical toxicity and toxicokinetics of GTI-2040, a phosphorothioate oligonucleotide targeting ribonucleotide reductase R2.
    Ferdinandi ES; Vassilakos A; Lee Y; Lightfoot J; Fitsialos D; Wright JA; Young AH
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):193-205. PubMed ID: 20886212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal distribution and metabolism of 2'-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
    Butler M; Hayes CS; Chappell A; Murray SF; Yaksh TL; Hua XY
    Neuroscience; 2005; 131(3):705-15. PubMed ID: 15730875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The detection of oligodeoxynucleotide molecules following uptake into mammalian cells.
    Hawley P; Gibson I
    Antisense Res Dev; 1992; 2(2):119-27. PubMed ID: 1392535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
    Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
    Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration.
    Graham MJ; Crooke ST; Monteith DK; Cooper SR; Lemonidis KM; Stecker KK; Martin MJ; Crooke RM
    J Pharmacol Exp Ther; 1998 Jul; 286(1):447-58. PubMed ID: 9655890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
    Zhang R; Iyer RP; Yu D; Tan W; Zhang X; Lu Z; Zhao H; Agrawal S
    J Pharmacol Exp Ther; 1996 Aug; 278(2):971-9. PubMed ID: 8768755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma.
    Yu RZ; Baker B; Chappell A; Geary RS; Cheung E; Levin AA
    Anal Biochem; 2002 May; 304(1):19-25. PubMed ID: 11969184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and selective cleavage of an oligodeoxynucleotide containing a bridged internucleotide 5'-phosphorothioate linkage.
    Mag M; Lüking S; Engels JW
    Nucleic Acids Res; 1991 Apr; 19(7):1437-41. PubMed ID: 2027751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
    Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
    Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydration of single-stranded phosphodiester and phosphorothioate oligodeoxyribonucleotides.
    White AP; Reeves KK; Snyder E; Farrell J; Powell JW; Mohan V; Griffey RH
    Nucleic Acids Res; 1996 Aug; 24(16):3261-6. PubMed ID: 8774910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats.
    Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides.
    Geary RS; Yu RZ; Levin AA
    Curr Opin Investig Drugs; 2001 Apr; 2(4):562-73. PubMed ID: 11566019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal and fetal distribution of a phosphorothioate oligonucleotide in rats after intravenous infusion.
    Soucy NV; Riley JP; Templin MV; Geary R; de Peyster A; Levin AA
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):22-8. PubMed ID: 16496297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs.
    Agrawal S; Tang JY; Sun D; Sarin PS; Zamecnik PC
    Ann N Y Acad Sci; 1992 Oct; 660():2-10. PubMed ID: 1340121
    [No Abstract]   [Full Text] [Related]  

  • 36. Biodistribution and metabolism of immunostimulatory oligodeoxynucleotide CPG 7909 in mouse and rat tissues following subcutaneous administration.
    Noll BO; McCluskie MJ; Sniatala T; Lohner A; Yuill S; Krieg AM; Schetter C; Davis HL; Uhlmann E
    Biochem Pharmacol; 2005 Mar; 69(6):981-91. PubMed ID: 15748709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid method for quantitation of oligodeoxynucleotide phosphorothioates in biological fluids and tissues.
    Temsamani J; Kubert M; Agrawal S
    Anal Biochem; 1993 Nov; 215(1):54-8. PubMed ID: 8297015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine.
    Mata JE; Jackson JD; Joshi SS; Tracewell WG; Pirruccello SJ; Murphy BJ; Bishop MR; Iversen PL
    J Hematother Stem Cell Res; 2000 Apr; 9(2):205-14. PubMed ID: 10813533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combined solid phase extraction/capillary gel electrophoresis method for the determination of phosphorothioate oligodeoxynucleotides in biological fluids, tissues and feces.
    Wu LX; Lu DD; Zhou Z; Zhang HY; Zhang YL; Wang SQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):361-8. PubMed ID: 19131282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of antisense oligonucleotides in rat liver homogenates.
    Crooke RM; Graham MJ; Martin MJ; Lemonidis KM; Wyrzykiewiecz T; Cummins LL
    J Pharmacol Exp Ther; 2000 Jan; 292(1):140-9. PubMed ID: 10604941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.